معرفی
Daniel Lundqvist is Professor of Neuroimaging at Karolinska Institutet, appointed to this position effective November 1, 2024. He is affiliated with the Department of Clinical Neuroscience within the Faculty of Medicine and serves as Director of the Centre for Imaging Research (CIR) at BioClinicum. Additionally, he leads the Swedish node of the EU project "TEF-Health - Testing and Experimentation Facilities for Health AI and Robotics" and is the Scientific Director of NatMEG - the National Facility for Magnetoencephalography. His Multimodal Brain Imaging research group investigates how brain structure, function, and neurochemistry shape human consciousness, perception, decisions, and actions.
Lundqvist earned his Doctor of Philosophy from Karolinska Institutet's Department of Clinical Neuroscience in 2003 and was awarded Docent (Associate Professor equivalent) status in 2016. His academic progression includes Senior Research Specialist (2021-2024) before his promotion to full Professor of Neuroimaging.
Dr. Lundqvist's research centers on advancing magnetoencephalography (MEG) and on-scalp MEG technologies to elucidate neuronal brain activity. His work bridges cognitive, affective, and clinical neuroscience with a focus on both fundamental brain mechanisms and clinical applications. He combines two complementary approaches: one focused on his own research projects investigating the brain-mind relationship, and another aimed at promoting the imaging ecosystem across Karolinska Institutet, Karolinska University Hospital, and Europe. His research spans epilepsy, Parkinson's disease, emotion processing, social neuroscience, and the development of novel neuroimaging methodologies, with increasing integration of AI and computational approaches in recent years.
His recent publications demonstrate a strong focus on advancing MEG technology for clinical applications, particularly on-scalp MEG. His work spans diverse neurological and psychiatric conditions while developing innovative imaging methodologies. A significant thread through his research is the application of advanced imaging techniques to understand both healthy brain function and neurological disorders, with particular emphasis on Parkinson's disease, epilepsy, and emotion processing.
- The cognitive neuropsychiatry of prediction systems in psychosis (Swedish Research Council, 2024-2026)
- CAPSI - Cancer related major depression treated with a single dose of psilocybin (Swedish Research Council, 2023-2026)
- TEF HEALTH (VINNOVA, 2022-2027)
- Finding a cognitive needle in a neural haystack (Swedish Research Council, 2022-2024)
- HD-MEG: High-definition neuroimaging for understanding the brain in health & disease (Swedish Research Council, 2022-2025)
- NatMEG: On-Scalp MEG Platform (Swedish Research Council, 2021-2025)
Lundqvist has supervised doctoral and master students as part of his extensive teaching contributions across neuroscience education and brain imaging methods. His leadership extends to directing major research facilities and collaborative projects, including his role as National Node lead for TEF-HEALTH, which received over SEK 100 million in EU funding. His Multimodal Brain Imaging group forms part of the Brain & Mind academic environment that brings together cognitive neuroscience researchers using various brain imaging techniques to understand brain function in health and disease.
